Cervicovaginal microbiota isolated from healthy women exhibit probiotic properties and antimicrobial activity against pathogens isolated from cervical cancer patients
- 16 July 2022
- journal article
- research article
- Published by Springer Nature in Archives of Microbiology
- Vol. 204 (8) , 1-16
Abstract
Abnormal cervicovaginal microbiota play an important role in HPV persistence and progression to cervical cancer. The present study aimed at isolating and identifying potential probiotics from vaginal swabs of healthy women and evaluating their activity against vaginal pathogens isolated from cervical cancer patients. Based on probiotic, acid-bile tolerance and antimicrobial properties, 13 lactic acid bacteria (LAB) from the healthy group were identified by MALDI TOF MS (Matrix Assisted Laser Desorption and Ionisation, Time Of Flight Mass Spectrometry). Among these, four strains, Lactobacillus gasseri P36Mops, Limosilactobacillus fermentum P37Mws, Lactobacillus delbrueckii P31Mcs and Enterococcus faecium P26Mcm, exhibited significant antimicrobial activity against 8 vaginal pathogens (Staphylococcus haemolyticus P41Tcs, Escherichia coli P30Tcs, E. coli P79Bcm, Enterococus faecalis P29Mops, E. faecalis P50Tws, E. faecalis P68Tcb, S. haemolyticus P48Bcb and S. haemolyticus P58Bcb) isolated from precancerous and cervical cancer patients. 16S rRNA sequencing of four potential probiotics revealed congruency with the MALDI-TOF MS identification and phylogenetic analysis showed genetic relationship with previously reported LAB strains. The selected LAB showed strain specific hydrophobicity (35.88–56.70%), auto-aggregation (35.26–61.39%) and antibiotic susceptibility. Interestingly, L. gasseri P36Mops was resistant to five standard antibiotics routinely used against urogenital or vaginal infections. LCMS (Liquid Chromatography Mass Spectrometry) analyses of the CFS (cell-free supernatant) of the four potential probiotics revealed the presence of metabolites such as N-(1-deoxy-1-fructosyl)valine, hygroline, acetoxy-2-hydroxy-16-heptadecen-4-one, avocadyne 4-acetate, avocadyne 2-acetate, taraxinic acid glucosyl ester, 6-hydroxypentadecanedioic acid, with reported antimicrobial activity. The overall data suggest the bio-therapeutic potential of the identified vaginal probiotics against cervical cancer-associated pathogens.Keywords
All Related Versions
Funding Information
- Department of Science and Technology, Ministry of Science and Technology (SR/WOS-A/LS-205/2017 (G) dated 06/09/2018)
This publication has 97 references indexed in Scilit:
- Probiotics enhance the clearance of human papillomavirus-related cervical lesionsEuropean Journal Of Cancer Prevention, 2013
- Vaginal Impact of the Oral Administration of Total Freeze-Dried Culture of LCR 35 in Healthy WomenInfectious Diseases in Obstetrics and Gynecology, 2012
- Study Prevalence of Verotoxigenic E.coli Isolated from Urinary Tract Infections (UTIs) in an Iranian Children HospitalThe Open Microbiology Journal, 2012
- A comparative study of oral single dose of metronidazole, tinidazole, secnidazole and ornidazole in bacterial vaginosisIndian Journal of Pharmacology, 2012
- Extended antimicrobial treatment of bacterial vaginosis combined with human lactobacilli to find the best treatment and minimize the risk of relapsesBMC Infectious Diseases, 2011
- Lactocin 160, a Bacteriocin Produced by Vaginal Lactobacillus rhamnosus, Targets Cytoplasmic Membranes of the Vaginal Pathogen, Gardnerella vaginalisProbiotics and Antimicrobial Proteins, 2009
- A facile synthesis, antibacterial, and antitubercular studies of some piperidin-4-one and tetrahydropyridine derivativesBioorganic & Medicinal Chemistry Letters, 2008
- Analysis of the Genome Sequence ofLactobacillus gasseriATCC 33323 Reveals the Molecular Basis of an Autochthonous Intestinal OrganismApplied and Environmental Microbiology, 2008
- Vaginal Microbiota and the Use of ProbioticsInterdisciplinary Perspectives on Infectious Diseases, 2008
- A randomized trial of metronidazole in asymptomatic bacterial vaginosis to prevent the acquisition of sexually transmitted diseasesAmerican Journal of Obstetrics and Gynecology, 2007